{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:31:34Z","timestamp":1790235094684,"version":"4.1.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC012"],"award-info":[{"award-number":["SRC012"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC012"],"award-info":[{"award-number":["SRC012"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC012"],"award-info":[{"award-number":["SRC012"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC 012"],"award-info":[{"award-number":["SRC 012"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC 012"],"award-info":[{"award-number":["SRC 012"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC 012"],"award-info":[{"award-number":["SRC 012"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC 012"],"award-info":[{"award-number":["SRC 012"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10620-022-07812-1","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:02:32Z","timestamp":1672840952000},"page":"1797-1814","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-1018","authenticated-orcid":false,"given":"L. R.","family":"Caley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"de Goffau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Floto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Parkhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Marsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-1868","authenticated-orcid":false,"given":"D. G.","family":"Peckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"issue":"1","key":"7812_CR1","doi-asserted-by":"publisher","first-page":"9624","DOI":"10.1038\/s41598-020-66598-2","volume":"10","author":"MT Al Bataineh","year":"2020","unstructured":"Al Bataineh MT, Dash NR, Bel Lassen P et al. Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: a pilot study. Sci Rep 2020;10:9624. https:\/\/doi.org\/10.1038\/s41598-020-66598-2.","journal-title":"Sci Rep"},{"key":"7812_CR2","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3389\/fmicb.2018.02147","volume":"9","author":"S Anand","year":"2018","unstructured":"Anand S, Mande SS. Diet, microbiota and gut-lung connection. Front Microbiol 2018;9:2147. https:\/\/doi.org\/10.3389\/fmicb.2018.02147.","journal-title":"Front Microbiol"},{"issue":"2","key":"7812_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jcf.2016.09.004","volume":"16","author":"JL Anderson","year":"2017","unstructured":"Anderson JL, Miles C, Tierney AC. Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: a systematic review. J Cyst Fibros 2017;16:186\u2013197. https:\/\/doi.org\/10.1016\/j.jcf.2016.09.004.","journal-title":"J Cyst Fibros"},{"key":"7812_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00274-19","author":"KM Antosca","year":"2019","unstructured":"Antosca KM, Chernikova DA, Price CE et al. Altered stool microbiota of infants with cystic fibrosis shows a reduction in genera associated with immune programming from birth. J Bacteriol. 2019. https:\/\/doi.org\/10.1128\/jb.00274-19.","journal-title":"J Bacteriol"},{"key":"7812_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3389\/fmicb.2016.01204","volume":"7","author":"S Arboleya","year":"2016","unstructured":"Arboleya S, Watkins C, Stanton C, Ross RP. Gut bifidobacteria populations in human health and aging. Front Microbiol 2016;7:1204. https:\/\/doi.org\/10.3389\/fmicb.2016.01204.","journal-title":"Front Microbiol"},{"issue":"307","key":"7812_CR6","doi-asserted-by":"publisher","first-page":"307ra512","DOI":"10.1126\/scitranslmed.aab2271","volume":"7","author":"MC Arrieta","year":"2015","unstructured":"Arrieta MC, Stiemsma LT, Dimitriu PA et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 2015;7:307ra512. https:\/\/doi.org\/10.1126\/scitranslmed.aab2271.","journal-title":"Sci Transl Med"},{"issue":"5","key":"7812_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1503\/cmaj.121189","volume":"185","author":"MB Azad","year":"2013","unstructured":"Azad MB, Konya T, Maughan H,  et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. Cmaj 2013;185:385\u2013394. https:\/\/doi.org\/10.1503\/cmaj.121189.","journal-title":"Cmaj"},{"issue":"5","key":"7812_CR8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.chom.2015.04.004","volume":"17","author":"F B\u00e4ckhed","year":"2015","unstructured":"B\u00e4ckhed F, Roswall J, Peng Y et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015;17:690\u2013703. https:\/\/doi.org\/10.1016\/j.chom.2015.04.004.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"7812_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1017\/s0007114518001435","volume":"120","author":"KL Barton","year":"2018","unstructured":"Barton KL, Chambers S, Anderson AS, Wrieden WL. Time to address the double inequality of differences in dietary intake between Scotland and England. Br J Nutr 2018;120:220\u2013226. https:\/\/doi.org\/10.1017\/s0007114518001435.","journal-title":"Br J Nutr"},{"issue":"2","key":"7812_CR10","doi-asserted-by":"publisher","first-page":"e87796","DOI":"10.1371\/journal.pone.0087796","volume":"9","author":"E Bruzzese","year":"2014","unstructured":"Bruzzese E, Callegari ML, Raia V et al. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial. PLoS ONE 2014;9:e87796. https:\/\/doi.org\/10.1371\/journal.pone.0087796.","journal-title":"PLoS ONE"},{"issue":"2","key":"7812_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/bj20082222","volume":"420","author":"N Burger-van Paassen","year":"2009","unstructured":"Burger-van Paassen N, Vincent A, Puiman PJ et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J 2009;420:211\u2013219. https:\/\/doi.org\/10.1042\/bj20082222.","journal-title":"Biochem J"},{"issue":"1","key":"7812_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","volume":"17","author":"DG Burke","year":"2017","unstructured":"Burke DG, Fouhy F, Harrison MJ et al. The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol 2017;17:58. https:\/\/doi.org\/10.1186\/s12866-017-0968-8.","journal-title":"BMC Microbiol"},{"issue":"3","key":"7812_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/mi.2017.75","volume":"11","author":"A Cait","year":"2018","unstructured":"Cait A, Hughes MR, Antignano F et al. Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids. Mucosal Immunol 2018;11:785\u2013795. https:\/\/doi.org\/10.1038\/mi.2017.75.","journal-title":"Mucosal Immunol"},{"issue":"7","key":"7812_CR14","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761\u20131772. https:\/\/doi.org\/10.2337\/db06-1491.","journal-title":"Diabetes"},{"key":"7812_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fcimb.2017.00444","volume":"7","author":"C Castellani","year":"2017","unstructured":"Castellani C, Singer G, Kashofer K et al. The influence of proton pump inhibitors on the fecal microbiome of infants with gastroesophageal reflux\u2014a prospective longitudinal interventional study. Front Cell Infect Microbiol 2017;7:444. https:\/\/doi.org\/10.3389\/fcimb.2017.00444.","journal-title":"Front Cell Infect Microbiol"},{"key":"7812_CR16","unstructured":"Centre for Reviews and Dissemination. Systematic Reviews: CRD's gudiance for undertaking reviews in health care, 2009. Retrieved 12th July from https:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews.pdf"},{"issue":"2","key":"7812_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5056\/jnm15025","volume":"21","author":"M Chichlowski","year":"2015","unstructured":"Chichlowski M, Rudolph C. Visceral pain and gastrointestinal microbiome. J Neurogastroenterol Motil 2015;21:172\u2013181. https:\/\/doi.org\/10.5056\/jnm15025.","journal-title":"J Neurogastroenterol Motil"},{"key":"7812_CR18","doi-asserted-by":"publisher","unstructured":"Coffey MJ, Garg M, Homaira N, Jaffe A, Ooi CY. Probiotics for people with cystic fibrosis. Cochrane Database Syst Rev. 2020;1:Article CD012949. https:\/\/doi.org\/10.1002\/14651858.CD012949.pub2.","DOI":"10.1002\/14651858.CD012949.pub2"},{"key":"7812_CR19","doi-asserted-by":"publisher","first-page":"18593","DOI":"10.1038\/s41598-019-55028-7","volume":"9","author":"MJ Coffey","year":"2019","unstructured":"Coffey MJ, Nielsen S, Wemheuer B et al. Gut microbiota in children with cystic fibrosis: a taxonomic and functional dysbiosis. Sci Rep 2019;9:18593. https:\/\/doi.org\/10.1038\/s41598-019-55028-7.","journal-title":"Sci Rep"},{"issue":"6","key":"7812_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","volume":"41","author":"M Corey","year":"1988","unstructured":"Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583\u2013591. https:\/\/doi.org\/10.1016\/0895-4356(88)90063-7.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"7812_CR21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/s0031-3955(16)33069-3","volume":"21","author":"DN Crozier","year":"1974","unstructured":"Crozier DN. Cystic fibrosis: a not-so-fatal disease. Pediatr Clin N Am 1974;21:935\u2013950. https:\/\/doi.org\/10.1016\/s0031-3955(16)33069-3.","journal-title":"Pediatr Clin N Am"},{"key":"7812_CR22","unstructured":"Cystic Fibrosis Trust. Nutritional Management of Cystic Fibrosis. Cystic Fibrosis Trust, 2016."},{"key":"7812_CR23","unstructured":"Cystic Fibrosis Trust. UK Cystic Fibrosis Registry: 2020 Annual Data Report, 2021. Retrieved 27 January from https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2021-12\/CF_Annual%20Report%202020_V8.pdf."},{"key":"7812_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00046-17","author":"E d\u2019Hennezel","year":"2017","unstructured":"d\u2019Hennezel E, Abubucker S, Murphy LO, Cullen TW. Total lipopolysaccharide from the human gut microbiome silences toll-like receptor signaling. mSystems. 2017. https:\/\/doi.org\/10.1128\/mSystems.00046-17.","journal-title":"mSystems"},{"issue":"1","key":"7812_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13073-020-0710-2","volume":"12","author":"G Dayama","year":"2020","unstructured":"Dayama G, Priya S, Niccum DE, Khoruts A, Blekhman R. Interactions between the gut microbiome and host gene regulation in cystic fibrosis. Genome Med 2020;12:12. https:\/\/doi.org\/10.1186\/s13073-020-0710-2.","journal-title":"Genome Med"},{"issue":"6","key":"7812_CR26","doi-asserted-by":"publisher","first-page":"e0198457","DOI":"10.1371\/journal.pone.0198457","volume":"13","author":"MB de Freitas","year":"2018","unstructured":"de Freitas MB, Moreira EAM, Tomio C et al. Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis. PLoS ONE 2018;13:e0198457. https:\/\/doi.org\/10.1371\/journal.pone.0198457.","journal-title":"PLoS ONE"},{"issue":"1","key":"7812_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41564-021-01023-6","volume":"7","author":"MC de Goffau","year":"2022","unstructured":"de Goffau MC, Jallow AT, Sanyang C et al. Gut microbiomes from Gambian infants reveal the development of a non-industrialized Prevotella-based trophic network. Nat Microbiol 2022;7:132\u2013144. https:\/\/doi.org\/10.1038\/s41564-021-01023-6.","journal-title":"Nat Microbiol"},{"issue":"12","key":"7812_CR28","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/hep4.1266","volume":"2","author":"D Debray","year":"2018","unstructured":"Debray D, El Mourabit H, Merabtene F et al. Diet-induced dysbiosis and genetic background synergize with cystic fibrosis transmembrane conductance regulator deficiency to promote cholangiopathy in mice. Hepatol Commun 2018;2:1533\u20131549. https:\/\/doi.org\/10.1002\/hep4.1266.","journal-title":"Hepatol Commun"},{"issue":"2","key":"7812_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jcf.2015.08.003","volume":"15","author":"G Debyser","year":"2016","unstructured":"Debyser G, Mesuere B, Clement L et al. Faecal proteomics: a tool to investigate dysbiosis and inflammation in patients with cystic fibrosis. J Cyst Fibros 2016;15:242\u2013250. https:\/\/doi.org\/10.1016\/j.jcf.2015.08.003.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"7812_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jcf.2014.02.007","volume":"13","author":"R del Campo","year":"2014","unstructured":"del Campo R, Garriga M, P\u00e9rez-Arag\u00f3n A et al. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study. J Cyst Fibros 2014;13:716\u2013722. https:\/\/doi.org\/10.1016\/j.jcf.2014.02.007.","journal-title":"J Cyst Fibros"},{"key":"7812_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.12.007","author":"NS Dellschaft","year":"2021","unstructured":"Dellschaft NS, Ng C, Hoad C et al. Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls. J Cyst Fibros. 2021. https:\/\/doi.org\/10.1016\/j.jcf.2021.12.007.","journal-title":"J Cyst Fibros"},{"issue":"127","key":"7812_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1183\/09059180.00008412","volume":"22","author":"N Derichs","year":"2013","unstructured":"Derichs N. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis. Eur Respir Rev 2013;22:58\u201365. https:\/\/doi.org\/10.1183\/09059180.00008412.","journal-title":"Eur Respir Rev"},{"issue":"Suppl 1","key":"7812_CR33","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1073\/pnas.1000087107","volume":"108","author":"L Dethlefsen","year":"2011","unstructured":"Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011;108:4554\u20134561. https:\/\/doi.org\/10.1073\/pnas.1000087107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7812_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7010019","author":"NE Diether","year":"2019","unstructured":"Diether NE, Willing BP. Microbial fermentation of dietary protein: an important factor in diet\u2013microbe\u2013host interaction. Microorganisms. 2019. https:\/\/doi.org\/10.3390\/microorganisms7010019.","journal-title":"Microorganisms"},{"key":"7812_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fcimb.2020.00077","volume":"10","author":"S Dorsaz","year":"2020","unstructured":"Dorsaz S, Charretier Y, Girard M et al. Changes in microbiota profiles after prolonged frozen storage of stool suspensions. Front Cell Infect Microbiol 2020;10:77. https:\/\/doi.org\/10.3389\/fcimb.2020.00077.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"7812_CR36","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1099\/00207713-52-5-1615","volume":"52","author":"SH Duncan","year":"2002","unstructured":"Duncan SH, Hold GL, Barcenilla A, Stewart CS, Flint HJ. Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. Int J Syst Evol Microbiol 2002;52:1615\u20131620. https:\/\/doi.org\/10.1099\/00207713-52-5-1615.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"22","key":"7812_CR37","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.1128\/aem.05933-11","volume":"77","author":"G Duytschaever","year":"2011","unstructured":"Duytschaever G, Huys G, Bekaert M, Boulanger L, De Boeck K, Vandamme P. Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl Environ Microbiol 2011;77:8015\u20138024. https:\/\/doi.org\/10.1128\/aem.05933-11.","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"7812_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jcf.2012.10.003","volume":"12","author":"G Duytschaever","year":"2013","unstructured":"Duytschaever G, Huys G, Bekaert M, Boulanger L, De Boeck K, Vandamme P. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. J Cyst Fibros 2013;12:206\u2013215. https:\/\/doi.org\/10.1016\/j.jcf.2012.10.003.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"7812_CR39","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jcf.2013.06.006","volume":"12","author":"G Duytschaever","year":"2013","unstructured":"Duytschaever G, Huys G, Boulanger L, De Boeck K, Vandamme P. Amoxicillin-clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings. J Cyst Fibros 2013;12:780\u2013783. https:\/\/doi.org\/10.1016\/j.jcf.2013.06.006.","journal-title":"J Cyst Fibros"},{"issue":"10059","key":"7812_CR40","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"S Elborn","year":"2016","unstructured":"Elborn S. Cystic fibrosis. Lancet 2016;388:2519\u20132531.","journal-title":"Lancet"},{"key":"7812_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050645","author":"R Enaud","year":"2019","unstructured":"Enaud R, Hooks KB, Barre A et al. Intestinal inflammation in children with cystic fibrosis is associated with crohn\u2019s-like microbiota disturbances. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8050645.","journal-title":"J Clin Med"},{"issue":"2","key":"7812_CR42","doi-asserted-by":"publisher","first-page":"e0116967","DOI":"10.1371\/journal.pone.0116967","volume":"10","author":"T Flass","year":"2015","unstructured":"Flass T, Tong S, Frank DN et al. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis. PLoS ONE 2015;10:e0116967. https:\/\/doi.org\/10.1371\/journal.pone.0116967.","journal-title":"PLoS ONE"},{"issue":"1","key":"7812_CR43","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.1038\/s41598-017-06880-y","volume":"7","author":"F Fouhy","year":"2017","unstructured":"Fouhy F, Ronan NJ, O\u2019Sullivan O et al. A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis. Sci Rep 2017;7:6685. https:\/\/doi.org\/10.1038\/s41598-017-06880-y.","journal-title":"Sci Rep"},{"key":"7812_CR44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3389\/fmicb.2018.00890","volume":"9","author":"I Garcia-Mantrana","year":"2018","unstructured":"Garcia-Mantrana I, Selma-Royo M, Alcantara C, Collado MC. Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population. Front Microbiol 2018;9:890. https:\/\/doi.org\/10.3389\/fmicb.2018.00890.","journal-title":"Front Microbiol"},{"key":"7812_CR45","doi-asserted-by":"publisher","unstructured":"Gelfond D, Borowitz D. Gastrointestinal complications of cystic fibrosis. Clin Gastroenterol Hepatol. 2013;11:333\u2013342; quiz e330\u2013331. https:\/\/doi.org\/10.1016\/j.cgh.2012.11.006.","DOI":"10.1016\/j.cgh.2012.11.006"},{"issue":"3","key":"7812_CR46","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1038\/ctg.2017.10","volume":"8","author":"D Gelfond","year":"2017","unstructured":"Gelfond D, Heltshe S, Ma C et al. Impact of CFTR modulation on intestinal pH, motility, and clinical outcomes in patients with cystic fibrosis and the G551D mutation. Clin Transl Gastroenterol 2017;8:e81. https:\/\/doi.org\/10.1038\/ctg.2017.10.","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"7812_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ismej.2010.92","volume":"5","author":"A Giongo","year":"2011","unstructured":"Giongo A, Gano KA, Crabb DB et al. Toward defining the autoimmune microbiome for type 1 diabetes. Isme j 2011;5:82\u201391. https:\/\/doi.org\/10.1038\/ismej.2010.92.","journal-title":"Isme j"},{"issue":"5","key":"7812_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/joim.12910","volume":"285","author":"GC Hansson","year":"2019","unstructured":"Hansson GC. Mucus and mucins in diseases of the intestinal and respiratory tracts. J Intern Med 2019;285:479\u2013490. https:\/\/doi.org\/10.1111\/joim.12910.","journal-title":"J Intern Med"},{"key":"7812_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-319-31248-4_7","volume-title":"Microbiota of the Human Body: Implications in Health and Disease","author":"HJM Harmsen","year":"2016","unstructured":"Harmsen HJM, de Goffau MC. The human gut microbiota. In: Schwiertz A, ed. Cham: Springer; 2016; 95\u2013108."},{"issue":"5","key":"7812_CR50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jcf.2012.07.003","volume":"11","author":"D Hartl","year":"2012","unstructured":"Hartl D, Gaggar A, Bruscia E et al. Innate immunity in cystic fibrosis lung disease. J Cyst Fibros 2012;11:363\u2013382. https:\/\/doi.org\/10.1016\/j.jcf.2012.07.003.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"7812_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41591-019-0714-x","volume":"26","author":"HS Hayden","year":"2020","unstructured":"Hayden HS, Eng A, Pope CE et al. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure. Nat Med 2020;26:215\u2013221. https:\/\/doi.org\/10.1038\/s41591-019-0714-x.","journal-title":"Nat Med"},{"issue":"7","key":"7812_CR52","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/2050640619841545","volume":"7","author":"B Hayee","year":"2019","unstructured":"Hayee B, Watson KL, Campbell S et al. A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders. United Eur Gastroenterol J 2019;7:881\u2013888. https:\/\/doi.org\/10.1177\/2050640619841545.","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"7812_CR53","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.1038\/s41598-021-92222-y","volume":"11","author":"JGE Henderickx","year":"2021","unstructured":"Henderickx JGE, Zwittink RD, Renes IB et al. Maturation of the preterm gastrointestinal tract can be defined by host and microbial markers for digestion and barrier defense. Sci Rep 2021;11:12808. https:\/\/doi.org\/10.1038\/s41598-021-92222-y.","journal-title":"Sci Rep"},{"issue":"26","key":"7812_CR54","doi-asserted-by":"publisher","first-page":"12672","DOI":"10.1073\/pnas.1904099116","volume":"116","author":"MT Henke","year":"2019","unstructured":"Henke MT, Kenny DJ, Cassilly CD, Vlamakis H, Xavier RJ, Clardy J. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn\u2019s disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci U S A 2019;116:12672\u201312677. https:\/\/doi.org\/10.1073\/pnas.1904099116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7812_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/9780470712184.ch8","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"JP Higgins","year":"2008","unstructured":"Higgins JP, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Deeks JJ, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: Wiley-Blackwell; 2008; 187\u2013241."},{"key":"7812_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/9780470712184.ch7","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"JP Higgins","year":"2008","unstructured":"Higgins JP, Deeks JJ. Selecting studies and collecting data. In: Higgins JPT, Deeks JJ, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: Wiley-Blackwell; 2008; 151\u2013185."},{"key":"7812_CR57","doi-asserted-by":"publisher","unstructured":"Hoen AG, Li J, Moulton LA et al. Associations between gut microbial colonization in early life and respiratory outcomes in cystic fibrosis. J Pediatr. 2015;167:138\u2013147.e131\u2013133. https:\/\/doi.org\/10.1016\/j.jpeds.2015.02.049.","DOI":"10.1016\/j.jpeds.2015.02.049"},{"issue":"3","key":"7812_CR58","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/cid\/cit715","volume":"58","author":"LR Hoffman","year":"2014","unstructured":"Hoffman LR, Pope CE, Hayden HS et al. Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis. Clin Infect Dis 2014;58:396\u2013399. https:\/\/doi.org\/10.1093\/cid\/cit715.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"7812_CR59","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1007\/s10620-018-5122-4","volume":"63","author":"M Hojo","year":"2018","unstructured":"Hojo M, Asahara T, Nagahara A et al. Gut microbiota composition before and after use of proton pump inhibitors. Dig Dis Sci 2018;63:2940\u20132949. https:\/\/doi.org\/10.1007\/s10620-018-5122-4.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"7812_CR60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4014\/jmb.1709.09017","volume":"28","author":"S Hong","year":"2018","unstructured":"Hong S, Yu JW. Prolonged exposure to lipopolysaccharide Induces NLRP3-independent maturation and secretion of interleukin (IL)-1\u03b2 in macrophages. J Microbiol Biotechnol 2018;28:115\u2013121. https:\/\/doi.org\/10.4014\/jmb.1709.09017.","journal-title":"J Microbiol Biotechnol"},{"key":"7812_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 2014;14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43.","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"7812_CR62","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann F, Bonder MJ, Vich Vila A et al. Proton pump inhibitors affect the gut microbiome. Gut 2016;65:740\u2013748. https:\/\/doi.org\/10.1136\/gutjnl-2015-310376.","journal-title":"Gut"},{"issue":"5","key":"7812_CR63","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3945\/ajcn.110.004119","volume":"93","author":"SA Jadin","year":"2011","unstructured":"Jadin SA, Wu GS, Zhang Z et al. Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program. Am J Clin Nutr 2011;93:1038\u20131047. https:\/\/doi.org\/10.3945\/ajcn.110.004119.","journal-title":"Am J Clin Nutr"},{"key":"7812_CR64","doi-asserted-by":"publisher","first-page":"e9836","DOI":"10.1371\/journal.pone.0009836","volume":"5","author":"HE Jakobsson","year":"2010","unstructured":"Jakobsson HE, Jernberg C, Andersson AF, Sj\u00f6lund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 2010;5:e9836. https:\/\/doi.org\/10.1371\/journal.pone.0009836.","journal-title":"PLoS ONE"},{"key":"7812_CR65","unstructured":"Joanna Briggs Institute. Critical Appraisal Checklist for Cohort Studies, 2017a. Retrieved 12th July from https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Cohort_Studies2017_0.pdf."},{"key":"7812_CR66","unstructured":"Joanna Briggs Institute. Critical Appraisal Checklist for Quasi-Experimental Studies, 2017b. Retrieved 12th July from https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Quasi-Experimental_Appraisal_Tool2017_0.pdf."},{"key":"7812_CR67","unstructured":"Joanna Briggs Institute. Critical Appraisal Checklist for Randomized Controlled Trials, 2017c. Retrieved 12th July from https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_RCTs_Appraisal_tool2017_0.pdf."},{"issue":"6","key":"7812_CR68","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.chom.2019.05.005","volume":"25","author":"AJ Johnson","year":"2019","unstructured":"Johnson AJ, Vangay P, Al-Ghalith GA et al. Daily sampling reveals personalized diet-microbiome associations in humans. Cell Host Microbe 2019;25:789-802.e785. https:\/\/doi.org\/10.1016\/j.chom.2019.05.005.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"7812_CR69","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1210\/jc.2017-01983","volume":"103","author":"M Kanhere","year":"2018","unstructured":"Kanhere M, He J, Chassaing B et al. Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab 2018;103:564\u2013574. https:\/\/doi.org\/10.1210\/jc.2017-01983.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7812_CR70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcmgh.2019.07.006","volume":"9","author":"AJ Kastl Jr","year":"2020","unstructured":"Kastl AJ Jr, Terry NA, Wu GD, Albenberg LG. The structure and function of the human small intestinal microbiota: current understanding and future directions. Cell Mol Gastroenterol Hepatol 2020;9:33\u201345. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.07.006.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"7812_CR71","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly CJ, Zheng L, Campbell EL et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 2015;17:662\u2013671. https:\/\/doi.org\/10.1016\/j.chom.2015.03.005.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"7812_CR72","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1183\/09031936.00166412","volume":"43","author":"E Kerem","year":"2014","unstructured":"Kerem E, Viviani L, Zolin A et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J 2014;43:125\u2013133. https:\/\/doi.org\/10.1183\/09031936.00166412.","journal-title":"Eur Respir J"},{"issue":"1","key":"7812_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1348-0421.2011.00398.x","volume":"56","author":"EV Khokhlova","year":"2012","unstructured":"Khokhlova EV, Smeianov VV, Efimov BA, Kafarskaia LI, Pavlova SI, Shkoporov AN. Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. Microbiol Immunol 2012;56:27\u201339. https:\/\/doi.org\/10.1111\/j.1348-0421.2011.00398.x.","journal-title":"Microbiol Immunol"},{"issue":"7","key":"7812_CR74","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/gutjnl-2014-309059","volume":"65","author":"KA Knoop","year":"2016","unstructured":"Knoop KA, McDonald KG, Kulkarni DH, Newberry RD. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 2016;65:1100\u20131109. https:\/\/doi.org\/10.1136\/gutjnl-2014-309059.","journal-title":"Gut"},{"issue":"1","key":"7812_CR75","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1038\/s41598-018-20827-x","volume":"8","author":"K Korpela","year":"2018","unstructured":"Korpela K, Blakstad EW, Moltu SJ et al. Intestinal microbiota development and gestational age in preterm neonates. Sci Rep 2018;8:2453. https:\/\/doi.org\/10.1038\/s41598-018-20827-x.","journal-title":"Sci Rep"},{"key":"7812_CR76","doi-asserted-by":"publisher","first-page":"10410","DOI":"10.1038\/ncomms10410","volume":"7","author":"K Korpela","year":"2016","unstructured":"Korpela K, Salonen A, Virta LJ et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 2016;7:10410. https:\/\/doi.org\/10.1038\/ncomms10410.","journal-title":"Nat Commun"},{"issue":"4","key":"7812_CR77","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jcf.2020.04.007","volume":"19","author":"M Kristensen","year":"2020","unstructured":"Kristensen M, Prevaes S, Kalkman G et al. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment. J Cyst Fibros 2020;19:553\u2013561. https:\/\/doi.org\/10.1016\/j.jcf.2020.04.007.","journal-title":"J Cyst Fibros"},{"key":"7812_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11050350","author":"MI Kristensen","year":"2021","unstructured":"Kristensen MI, de Winter-de Groot KM, Berkers G et al. Individual and group response of treatment with ivacaftor on airway and gut microbiota in people with CF and a S1251N mutation. J Pers Med. 2021. https:\/\/doi.org\/10.3390\/jpm11050350.","journal-title":"J Pers Med"},{"issue":"6","key":"7812_CR79","doi-asserted-by":"publisher","first-page":"e20956","DOI":"10.1371\/journal.pone.0020956","volume":"6","author":"PS Kumar","year":"2011","unstructured":"Kumar PS, Brooker MR, Dowd SE, Camerlengo T. Target region selection is a critical determinant of community fingerprints generated by 16S pyrosequencing. PLoS ONE 2011;6:e20956. https:\/\/doi.org\/10.1371\/journal.pone.0020956.","journal-title":"PLoS ONE"},{"key":"7812_CR80","unstructured":"Law MSD, Pollock N, Letts L, Bosch J, Westmorland M. Guidelines for Critical Review Form-Quantitative Studies, 1998. Retrieved 12th July from https:\/\/healthsci.mcmaster.ca\/docs\/librariesprovider130\/default-document-library\/guidelines-for-critical-review-form-quantiative-studies-english.pdf?sfvrsn=ee9f6c19_2."},{"issue":"4","key":"7812_CR81","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.clnu.2016.06.029","volume":"36","author":"L Li","year":"2017","unstructured":"Li L, Krause L, Somerset S. Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis. Clin Nutr 2017;36:1097\u20131104. https:\/\/doi.org\/10.1016\/j.clnu.2016.06.029.","journal-title":"Clin Nutr"},{"key":"7812_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/nu10091264","author":"L Li","year":"2018","unstructured":"Li L, Somerset S. Associations between flavonoid intakes and gut microbiota in a group of adults with cystic fibrosis. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10091264.","journal-title":"Nutrients"},{"key":"7812_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11020132","author":"X Liang","year":"2021","unstructured":"Liang X, Bouhamdan M, Hou X et al. Intestinal dysbiosis in young cystic fibrosis rabbits. J Pers Med. 2021. https:\/\/doi.org\/10.3390\/jpm11020132.","journal-title":"J Pers Med"},{"key":"7812_CR84","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj 2009;339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700.","journal-title":"Bmj"},{"issue":"7","key":"7812_CR85","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/ppul.24766","volume":"55","author":"BR Loman","year":"2020","unstructured":"Loman BR, Shrestha CL, Thompson R et al. Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis. Pediatr Pulmonol 2020;55:1661\u20131670. https:\/\/doi.org\/10.1002\/ppul.24766.","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"7812_CR86","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ismej.2010.133","volume":"5","author":"C Lozupone","year":"2011","unstructured":"Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. UniFrac: an effective distance metric for microbial community comparison. Isme j 2011;5:169\u2013172. https:\/\/doi.org\/10.1038\/ismej.2010.133.","journal-title":"Isme j"},{"issue":"1","key":"7812_CR87","doi-asserted-by":"publisher","first-page":"15792","DOI":"10.1038\/s41598-020-72635-x","volume":"10","author":"J Ma","year":"2020","unstructured":"Ma J, Li Z, Zhang W et al. Comparison of gut microbiota in exclusively breast-fed and formula-fed babies: a study of 91 term infants. Sci Rep 2020;10:15792. https:\/\/doi.org\/10.1038\/s41598-020-72635-x.","journal-title":"Sci Rep"},{"key":"7812_CR88","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00251-12","author":"JC Madan","year":"2012","unstructured":"Madan JC, Koestler DC, Stanton BA et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. Mbio. 2012. https:\/\/doi.org\/10.1128\/mBio.00251-12.","journal-title":"Mbio"},{"issue":"9","key":"7812_CR89","doi-asserted-by":"publisher","first-page":"e13883","DOI":"10.1111\/nmo.13883","volume":"32","author":"C Malagelada","year":"2020","unstructured":"Malagelada C, Bendez\u00fa RA, Segu\u00ed S et al. Motor dysfunction of the gut in cystic fibrosis. Neurogastroenterol Motil 2020;32:e13883. https:\/\/doi.org\/10.1111\/nmo.13883.","journal-title":"Neurogastroenterol Motil"},{"key":"7812_CR90","doi-asserted-by":"publisher","first-page":"22493","DOI":"10.1038\/srep22493","volume":"6","author":"O Manor","year":"2016","unstructured":"Manor O, Levy R, Pope CE et al. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis. Sci Rep 2016;6:22493. https:\/\/doi.org\/10.1038\/srep22493.","journal-title":"Sci Rep"},{"issue":"3","key":"7812_CR91","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jcf.2021.11.014","volume":"21","author":"R Marsh","year":"2022","unstructured":"Marsh R, Gavillet H, Hanson L et al. Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis. J Cyst Fibros 2022;21:506\u2013513. https:\/\/doi.org\/10.1016\/j.jcf.2021.11.014.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"7812_CR92","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.1038\/s41598-019-44888-8","volume":"9","author":"N Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez N, Hidalgo-Cantabrana C, Delgado S, Margolles A, S\u00e1nchez B. Filling the gap between collection, transport and storage of the human gut microbiota. Sci Rep 2019;9:8327. https:\/\/doi.org\/10.1038\/s41598-019-44888-8.","journal-title":"Sci Rep"},{"issue":"7","key":"7812_CR93","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1073\/pnas.1714373115","volume":"115","author":"S Matamouros","year":"2018","unstructured":"Matamouros S, Hayden HS, Hager KR et al. Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis. Proc Natl Acad Sci U S A 2018;115:1605\u20131610. https:\/\/doi.org\/10.1073\/pnas.1714373115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"7812_CR94","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1128\/cvi.00310-09","volume":"16","author":"G Matera","year":"2009","unstructured":"Matera G, Muto V, Vinci M et al. Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clin Vaccine Immunol 2009;16:1804\u20131809. https:\/\/doi.org\/10.1128\/cvi.00310-09.","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"7812_CR95","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/imr.12556","volume":"278","author":"C McKenzie","year":"2017","unstructured":"McKenzie C, Tan J, Macia L, Mackay CR. The nutrition-gut microbiome-physiology axis and allergic diseases. Immunol Rev 2017;278:277\u2013295. https:\/\/doi.org\/10.1111\/imr.12556.","journal-title":"Immunol Rev"},{"issue":"1","key":"7812_CR96","doi-asserted-by":"publisher","first-page":"e1008251","DOI":"10.1371\/journal.ppat.1008251","volume":"16","author":"SM Meeker","year":"2020","unstructured":"Meeker SM, Mears KS, Sangwan N et al. CFTR dysregulation drives active selection of the gut microbiome. PLoS Pathog 2020;16:e1008251. https:\/\/doi.org\/10.1371\/journal.ppat.1008251.","journal-title":"PLoS Pathog"},{"issue":"19","key":"7812_CR97","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","volume":"381","author":"PG Middleton","year":"2019","unstructured":"Middleton PG, Mall MA, D\u0159ev\u00ednek P et al. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 2019;381:1809\u20131819. https:\/\/doi.org\/10.1056\/NEJMoa1908639.","journal-title":"N Engl J Med"},{"key":"7812_CR98","doi-asserted-by":"publisher","DOI":"10.1093\/femsec\/fiw230","author":"F Miragoli","year":"2017","unstructured":"Miragoli F, Federici S, Ferrari S et al. Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota. FEMS Microbiol Ecol. 2017. https:\/\/doi.org\/10.1093\/femsec\/fiw230.","journal-title":"FEMS Microbiol Ecol"},{"key":"7812_CR99","doi-asserted-by":"publisher","DOI":"10.3402\/fnr.v55i0.7561","author":"IE Moen","year":"2011","unstructured":"Moen IE, Nilsson K, Andersson A et al. Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations. Food Nutr Res. 2011. https:\/\/doi.org\/10.3402\/fnr.v55i0.7561.","journal-title":"Food Nutr Res"},{"issue":"7","key":"7812_CR100","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"key":"7812_CR101","unstructured":"National Center for Chronic Disease Prevention and Health Promotion. Breastfeeding Rates, 2020. https:\/\/www.cdc.gov\/breastfeeding\/data\/nis_data\/index.htm."},{"issue":"3","key":"7812_CR102","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/mpg.0000000000002185","volume":"68","author":"LCL Neri","year":"2019","unstructured":"Neri LCL, Taminato M, Silva Filho L. Systematic review of probiotics for cystic fibrosis patients: moving forward. J Pediatr Gastroenterol Nutr 2019;68:394\u2013399. https:\/\/doi.org\/10.1097\/mpg.0000000000002185.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7812_CR103","doi-asserted-by":"publisher","first-page":"24857","DOI":"10.1038\/srep24857","volume":"6","author":"S Nielsen","year":"2016","unstructured":"Nielsen S, Needham B, Leach ST et al. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis. Sci Rep 2016;6:24857. https:\/\/doi.org\/10.1038\/srep24857.","journal-title":"Sci Rep"},{"issue":"Suppl 2","key":"7812_CR104","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000457920","volume":"70","author":"WH Oddy","year":"2017","unstructured":"Oddy WH. Breastfeeding, childhood asthma, and allergic disease. Ann Nutr Metab 2017;70:26\u201336. https:\/\/doi.org\/10.1159\/000457920.","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"7812_CR105","doi-asserted-by":"publisher","first-page":"17834","DOI":"10.1038\/s41598-018-36364-6","volume":"8","author":"CY Ooi","year":"2018","unstructured":"Ooi CY, Syed SA, Rossi L et al. Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation. Sci Rep 2018;8:17834. https:\/\/doi.org\/10.1038\/s41598-018-36364-6.","journal-title":"Sci Rep"},{"issue":"9","key":"7812_CR106","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009;139:1619\u20131625. https:\/\/doi.org\/10.3945\/jn.109.104638.","journal-title":"J Nutr"},{"issue":"1","key":"7812_CR107","doi-asserted-by":"publisher","first-page":"e00204","DOI":"10.1002\/rcr2.204","volume":"5","author":"F Piccolo","year":"2017","unstructured":"Piccolo F, Tai AS, Ee H, Mulrennan S, Bell S, Ryan G. Clostridium difficile infection in cystic fibrosis: an uncommon but life-threatening complication. Respirol Case Rep 2017;5:e00204. https:\/\/doi.org\/10.1002\/rcr2.204.","journal-title":"Respirol Case Rep"},{"key":"7812_CR108","unstructured":"PROSPERO. York, England: Centre for Reviews and Dissemination, University of York, . Retrieved 31st of July from https:\/\/www.crd.york.ac.uk\/PROSPERO\/#searchadvanced."},{"issue":"7516","key":"7812_CR109","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin N, Yang F, Li A et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014;513:59\u201364. https:\/\/doi.org\/10.1038\/nature13568.","journal-title":"Nature"},{"issue":"4","key":"7812_CR110","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbrc.2015.12.083","volume":"469","author":"R Ranjan","year":"2016","unstructured":"Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun 2016;469:967\u2013977. https:\/\/doi.org\/10.1016\/j.bbrc.2015.12.083.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"7812_CR111","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12890-022-02078-9","volume":"22","author":"KJ Ray","year":"2022","unstructured":"Ray KJ, Santee C, McCauley K, Panzer AR, Lynch SV. Gut Bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis. BMC Pulm Med 2022;22:287. https:\/\/doi.org\/10.1186\/s12890-022-02078-9.","journal-title":"BMC Pulm Med"},{"issue":"23","key":"7812_CR112","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.3748\/wjg.v12.i23.3729","volume":"12","author":"CU Riedel","year":"2006","unstructured":"Riedel CU, Foata F, Philippe D, Adolfsson O, Eikmanns BJ, Blum S. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World J Gastroenterol 2006;12:3729\u20133735. https:\/\/doi.org\/10.3748\/wjg.v12.i23.3729.","journal-title":"World J Gastroenterol"},{"key":"7812_CR113","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.3389\/fimmu.2019.02494","volume":"10","author":"T Ruohtula","year":"2019","unstructured":"Ruohtula T, de Goffau MC, Nieminen JK et al. Maturation of gut microbiota and circulating regulatory T cells and development of IgE sensitization in early life. Front Immunol 2019;10:2494. https:\/\/doi.org\/10.3389\/fimmu.2019.02494.","journal-title":"Front Immunol"},{"key":"7812_CR114","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.mam.2019.05.001","volume":"69","author":"E Saus","year":"2019","unstructured":"Saus E, Iraola-Guzm\u00e1n S, Willis JR, Brunet-Vega A, Gabald\u00f3n T. Microbiome and colorectal cancer: roles in carcinogenesis and clinical potential. Mol Aspects Med 2019;69:93\u2013106. https:\/\/doi.org\/10.1016\/j.mam.2019.05.001.","journal-title":"Mol Aspects Med"},{"key":"7812_CR115","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49248","author":"T Scambler","year":"2019","unstructured":"Scambler T, Jarosz-Griffiths HH, Lara-Reyna S et al. ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis. Elife. 2019. https:\/\/doi.org\/10.7554\/eLife.49248.","journal-title":"Elife"},{"issue":"5","key":"7812_CR116","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jcf.2012.03.007","volume":"11","author":"PD Scanlan","year":"2012","unstructured":"Scanlan PD, Buckling A, Kong W, Wild Y, Lynch SV, Harrison F. Gut dysbiosis in cystic fibrosis. J Cyst Fibros 2012;11:454\u2013455. https:\/\/doi.org\/10.1016\/j.jcf.2012.03.007.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"7812_CR117","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/art.38892","volume":"67","author":"JU Scher","year":"2015","unstructured":"Scher JU, Ubeda C, Artacho A et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 2015;67:128\u2013139. https:\/\/doi.org\/10.1002\/art.38892.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"7812_CR118","doi-asserted-by":"publisher","first-page":"e6117678","DOI":"10.1371\/journal.pone.0061176","volume":"8","author":"S Schippa","year":"2013","unstructured":"Schippa S, Iebba V, Santangelo F et al. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS ONE 2013;8:e6117678. https:\/\/doi.org\/10.1371\/journal.pone.0061176.","journal-title":"PLoS ONE"},{"issue":"2","key":"7812_CR119","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","volume":"50","author":"J Schulthess","year":"2019","unstructured":"Schulthess J, Pandey S, Capitani M et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 2019;50:432\u2013445.e437. https:\/\/doi.org\/10.1016\/j.immuni.2018.12.018.","journal-title":"Immunity"},{"issue":"3","key":"7812_CR120","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","volume":"1","author":"KJP Schwenger","year":"2019","unstructured":"Schwenger KJP, Clermont-Dejean N, Allard JP. The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep 2019;1:214\u2013226. https:\/\/doi.org\/10.1016\/j.jhepr.2019.04.004.","journal-title":"JHEP Rep"},{"issue":"3","key":"7812_CR121","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cell.2016.01.013","volume":"164","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 2016;164:337\u2013340. https:\/\/doi.org\/10.1016\/j.cell.2016.01.013.","journal-title":"Cell"},{"issue":"9133","key":"7812_CR122","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/s0140-6736(98)03038-4","volume":"352","author":"H Sidhu","year":"1998","unstructured":"Sidhu H, Hoppe B, Hesse A et al. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 1998;352:1026\u20131029. https:\/\/doi.org\/10.1016\/s0140-6736(98)03038-4.","journal-title":"Lancet"},{"issue":"1","key":"7812_CR123","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","volume":"62","author":"M Simr\u00e9n","year":"2013","unstructured":"Simr\u00e9n M, Barbara G, Flint HJ et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159\u2013176. https:\/\/doi.org\/10.1136\/gutjnl-2012-302167.","journal-title":"Gut"},{"key":"7812_CR124","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pharmthera.2016.04.007","volume":"164","author":"S Sivaprakasam","year":"2016","unstructured":"Sivaprakasam S, Prasad PD, Singh N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther 2016;164:144\u2013151. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.04.007.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"7812_CR125","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/adc.82.5.394","volume":"82","author":"RL Smyth","year":"2000","unstructured":"Smyth RL, Croft NM, O\u2019Hea U, Marshall TG, Ferguson A. Intestinal inflammation in cystic fibrosis. Arch Dis Child 2000;82:394\u2013399. https:\/\/doi.org\/10.1136\/adc.82.5.394.","journal-title":"Arch Dis Child"},{"key":"7812_CR126","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","volume":"201","author":"VA Stallings","year":"2018","unstructured":"Stallings VA, Sainath N, Oberle M, Bertolaso C, Schall JI. Energy balance and mechanisms of weight gain with ivacaftor treatment of cystic fibrosis gating mutations. J Pediatr 2018;201:229-237.e224. https:\/\/doi.org\/10.1016\/j.jpeds.2018.05.018.","journal-title":"J Pediatr"},{"issue":"7728","key":"7812_CR127","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-018-0617-x","volume":"562","author":"CJ Stewart","year":"2018","unstructured":"Stewart CJ, Ajami NJ, O\u2019Brien JL et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 2018;562:583\u2013588. https:\/\/doi.org\/10.1038\/s41586-018-0617-x.","journal-title":"Nature"},{"key":"7812_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.03.010","author":"S Szentpetery","year":"2022","unstructured":"Szentpetery S, Fernandez GS, Schechter MS, Jain R, Flume PA, Fink AK. Obesity in cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry. J Cyst Fibros. 2022. https:\/\/doi.org\/10.1016\/j.jcf.2022.03.010.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"7812_CR129","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jcf.2020.11.009","volume":"20","author":"SL Taylor","year":"2021","unstructured":"Taylor SL, Leong LEX, Sims SK et al. The cystic fibrosis gut as a potential source of multidrug resistant pathogens. J Cyst Fibros 2021;20:413\u2013420. https:\/\/doi.org\/10.1016\/j.jcf.2020.11.009.","journal-title":"J Cyst Fibros"},{"key":"7812_CR130","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1038\/ncomms4114","volume":"5","author":"CM Theriot","year":"2014","unstructured":"Theriot CM, Koenigsknecht MJ, Carlson PE Jr et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 2014;5:3114. https:\/\/doi.org\/10.1038\/ncomms4114.","journal-title":"Nat Commun"},{"issue":"14","key":"7812_CR131","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1042\/bcj20200426","volume":"477","author":"R Trivedi","year":"2020","unstructured":"Trivedi R, Barve K. Gut microbiome a promising target for management of respiratory diseases. Biochem J 2020;477:2679\u20132696. https:\/\/doi.org\/10.1042\/bcj20200426.","journal-title":"Biochem J"},{"issue":"5","key":"7812_CR132","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.immuni.2018.04.022","volume":"48","author":"A Trompette","year":"2018","unstructured":"Trompette A, Gollwitzer ES, Pattaroni C et al. Dietary fiber confers protection against flu by shaping Ly6c(\u2212) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism. Immunity 2018;48:992\u20131005.e1008. https:\/\/doi.org\/10.1016\/j.immuni.2018.04.022.","journal-title":"Immunity"},{"key":"7812_CR133","doi-asserted-by":"publisher","first-page":"k2179","DOI":"10.1136\/bmj.k2179","volume":"361","author":"AM Valdes","year":"2018","unstructured":"Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. Bmj 2018;361:k2179. https:\/\/doi.org\/10.1136\/bmj.k2179.","journal-title":"Bmj"},{"issue":"4","key":"7812_CR134","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","volume":"4","author":"M Valles-Colomer","year":"2019","unstructured":"Valles-Colomer M, Falony G, Darzi Y et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 2019;4:623\u2013632. https:\/\/doi.org\/10.1038\/s41564-018-0337-x.","journal-title":"Nat Microbiol"},{"key":"7812_CR135","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clnesp.2017.01.007","volume":"18","author":"S Van Biervliet","year":"2017","unstructured":"Van Biervliet S, Declercq D, Somerset S. Clinical effects of probiotics in cystic fibrosis patients: a systematic review. Clin Nutr ESPEN 2017;18:37\u201343. https:\/\/doi.org\/10.1016\/j.clnesp.2017.01.007.","journal-title":"Clin Nutr ESPEN"},{"key":"7812_CR136","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clnesp.2018.06.008","volume":"27","author":"S Van Biervliet","year":"2018","unstructured":"Van Biervliet S, Hauser B, Verhulst S et al. Probiotics in cystic fibrosis patients: a double blind crossover placebo controlled study: Pilot study from the ESPGHAN Working Group on Pancreas\/CF. Clin Nutr ESPEN 2018;27:59\u201365. https:\/\/doi.org\/10.1016\/j.clnesp.2018.06.008.","journal-title":"Clin Nutr ESPEN"},{"issue":"5","key":"7812_CR137","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ismej.2012.158","volume":"7","author":"P Van den Abbeele","year":"2013","unstructured":"Van den Abbeele P, Belzer C, Goossens M et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. Isme j 2013;7:949\u2013961. https:\/\/doi.org\/10.1038\/ismej.2012.158.","journal-title":"Isme j"},{"issue":"2","key":"7812_CR138","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/1574-6941.12127","volume":"85","author":"B van den Bogert","year":"2013","unstructured":"van den Bogert B, Erkus O, Boekhorst J et al. Diversity of human small intestinal Streptococcus and Veillonella populations. FEMS Microbiol Ecol 2013;85:376\u2013388. https:\/\/doi.org\/10.1111\/1574-6941.12127.","journal-title":"FEMS Microbiol Ecol"},{"issue":"4","key":"7812_CR139","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.cell.2016.04.007","volume":"165","author":"T Vatanen","year":"2016","unstructured":"Vatanen T, Kostic AD, d\u2019Hennezel E et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 2016;165:842\u2013853. https:\/\/doi.org\/10.1016\/j.cell.2016.04.007.","journal-title":"Cell"},{"key":"7812_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/nu9121342","author":"P Vernocchi","year":"2017","unstructured":"Vernocchi P, Del Chierico F, Quagliariello A, Ercolini D, Lucidi V, Putignani L. A metagenomic and in silico functional prediction of gut microbiota profiles may concur in discovering new cystic fibrosis patient-targeted probiotics. Nutrients. 2017. https:\/\/doi.org\/10.3390\/nu9121342.","journal-title":"Nutrients"},{"issue":"12","key":"7812_CR141","doi-asserted-by":"publisher","first-page":"e0208171","DOI":"10.1371\/journal.pone.0208171","volume":"13","author":"P Vernocchi","year":"2018","unstructured":"Vernocchi P, Del Chierico F, Russo A et al. Gut microbiota signatures in cystic fibrosis: loss of host CFTR function drives the microbiota enterophenotype. PLoS ONE 2018;13:e0208171. https:\/\/doi.org\/10.1371\/journal.pone.0208171.","journal-title":"PLoS ONE"},{"issue":"7808","key":"7812_CR142","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","volume":"581","author":"S Vieira-Silva","year":"2020","unstructured":"Vieira-Silva S, Falony G, Belda E et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 2020;581:310\u2013315. https:\/\/doi.org\/10.1038\/s41586-020-2269-x.","journal-title":"Nature"},{"issue":"8","key":"7812_CR143","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/aje\/kwr400","volume":"175","author":"L Virta","year":"2012","unstructured":"Virta L, Auvinen A, Helenius H, Huovinen P, Kolho KL. Association of repeated exposure to antibiotics with the development of pediatric Crohn\u2019s disease\u2014a nationwide, register-based Finnish case-control study. Am J Epidemiol 2012;175:775\u2013784. https:\/\/doi.org\/10.1093\/aje\/kwr400.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"7812_CR144","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007;4:e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296.","journal-title":"PLoS Med"},{"issue":"1","key":"7812_CR145","doi-asserted-by":"publisher","first-page":"1997296","DOI":"10.1080\/19490976.2021.1997296","volume":"14","author":"B Waclawikov\u00e1","year":"2022","unstructured":"Waclawikov\u00e1 B, Codutti A, Alim K, El Aidy S. Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies. Gut Microbes 2022;14:1997296. https:\/\/doi.org\/10.1080\/19490976.2021.1997296.","journal-title":"Gut Microbes"},{"issue":"12","key":"7812_CR146","doi-asserted-by":"publisher","first-page":"e1007524","DOI":"10.1371\/journal.pcbi.1007524","volume":"15","author":"T Wang","year":"2019","unstructured":"Wang T, Goyal A, Dubinkina V, Maslov S. Evidence for a multi-level trophic organization of the human gut microbiome. PLoS Comput Biol 2019;15:e1007524. https:\/\/doi.org\/10.1371\/journal.pcbi.1007524.","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"7812_CR147","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/19490976.2018.1534512","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Leong LEX, Keating RL et al. Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut. Gut Microbes 2019;10:367\u2013381. https:\/\/doi.org\/10.1080\/19490976.2018.1534512.","journal-title":"Gut Microbes"},{"issue":"29","key":"7812_CR148","doi-asserted-by":"publisher","first-page":"46158","DOI":"10.18632\/oncotarget.10064","volume":"7","author":"Z Wei","year":"2016","unstructured":"Wei Z, Cao S, Liu S et al. Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients\u2019 survival? A pilot study on relevant mechanism. Oncotarget 2016;7:46158\u201346172. https:\/\/doi.org\/10.18632\/oncotarget.10064.","journal-title":"Oncotarget"},{"issue":"7","key":"7812_CR149","doi-asserted-by":"publisher","first-page":"1468s","DOI":"10.3945\/jn.116.240754","volume":"147","author":"L Wen","year":"2017","unstructured":"Wen L, Duffy A. Factors influencing the gut microbiota, inflammation, and Type 2 diabetes. J Nutr 2017;147:1468s\u20131475s. https:\/\/doi.org\/10.3945\/jn.116.240754.","journal-title":"J Nutr"},{"key":"7812_CR150","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.3389\/fimmu.2019.03141","volume":"10","author":"EA Yamamoto","year":"2019","unstructured":"Yamamoto EA, J\u00f8rgensen TN. Relationships between vitamin D, Gut microbiome, and systemic autoimmunity. Front Immunol 2019;10:3141. https:\/\/doi.org\/10.3389\/fimmu.2019.03141.","journal-title":"Front Immunol"},{"issue":"10","key":"7812_CR151","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1242\/dmm.016428","volume":"7","author":"Y Yang","year":"2014","unstructured":"Yang Y, Jobin C. Microbial imbalance and intestinal pathologies: connections and contributions. Dis Model Mech 2014;7:1131\u20131142. https:\/\/doi.org\/10.1242\/dmm.016428.","journal-title":"Dis Model Mech"},{"issue":"1","key":"7812_CR152","doi-asserted-by":"publisher","first-page":"e0000422","DOI":"10.1128\/msystems.00004-22","volume":"7","author":"S Y\u0131ld\u0131r\u0131m","year":"2022","unstructured":"Y\u0131ld\u0131r\u0131m S, Nalbanto\u011flu \u00d6U, Bayraktar A et al. Stratification of the gut microbiota composition landscape across the Alzheimer\u2019s Disease Continuum in a Turkish Cohort. mSystems 2022;7:e0000422-23. https:\/\/doi.org\/10.1128\/msystems.00004-22.","journal-title":"mSystems"},{"key":"7812_CR153","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fcimb.2019.00239","volume":"9","author":"R Zhai","year":"2019","unstructured":"Zhai R, Xue X, Zhang L, Yang X, Zhao L, Zhang C. Strain-specific anti-inflammatory properties of two Akkermansia muciniphila strains on chronic colitis in mice. Front Cell Infect Microbiol 2019;9:239. https:\/\/doi.org\/10.3389\/fcimb.2019.00239.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"7812_CR154","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1136\/gutjnl-2019-318593","volume":"68","author":"J Zhang","year":"2019","unstructured":"Zhang J, Haines C, Watson AJM et al. Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989\u20132012: a matched case\u2013control study. Gut 2019;68:1971\u20131978. https:\/\/doi.org\/10.1136\/gutjnl-2019-318593.","journal-title":"Gut"},{"issue":"7","key":"7812_CR155","doi-asserted-by":"publisher","first-page":"e3043","DOI":"10.1002\/dmrr.3043","volume":"34","author":"P Zheng","year":"2018","unstructured":"Zheng P, Li Z, Zhou Z. Gut microbiome in type 1 diabetes: a comprehensive review. Diabetes Metab Res Rev 2018;34:e3043. https:\/\/doi.org\/10.1002\/dmrr.3043.","journal-title":"Diabetes Metab Res Rev"},{"key":"7812_CR156","doi-asserted-by":"publisher","first-page":"834485","DOI":"10.3389\/fcimb.2022.834485","volume":"12","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Sun B, Yu D, Zhu C. Gut microbiota: an important player in type 2 diabetes mellitus. Front Cell Infect Microbiol 2022;12:834485. https:\/\/doi.org\/10.3389\/fcimb.2022.834485.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07812-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07812-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07812-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:21:13Z","timestamp":1682468473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07812-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":156,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["7812"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07812-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}